ghk cu injections before and after vs. 3 months of GHK-Cu peptide therapy πͺ β’ smoother texture, more even tone, skin that looks healthier overall. Small peptide, big difference π 12 Weeks of GHK-Cu Before
Description
FOXO4-DRI (also known as Proxofim) is a synthetic D-retro-inverso peptide designed to selectively induce apoptosis in senescent cells by disrupting the FOXO4p53 protein interaction [1] [2]

For example: Liposomes enhance encapsulation and penetration Nano-emulsions improve dispersion and skin interaction Exosome-inspired systems support targeted delivery Micro-stimulation technologies increase permeability In particular, combining GHK-Cu with physical delivery systems can significantly enhance performance

not primarily appetite-driven (OUP Academic) Expected weight loss (this is where many people get misled) In major obesity trials: Semaglutide 2.4 mg weekly: ~14.9% mean weight loss at 68 weeks (STEP-1) (PubMed) Tirzepatide: ~15.0% to ~20.9% mean weight loss at 72 weeks , dose-dependent (SURMOUNT-1) (PubMed) AOD-9604s best-known human signal is kilograms, not double-digit percentages , and later studies did not sustain a strong obesity-drug profile
F.SoumyanathA
